Amoxil (amoxicillin) SPC and PIL updates
Please note that the Amoxil SPCs and PILs were updated on 2nd March 2016 in line with a European Harmonisation Process. Please see the Amoxil product page for further information.
View our products
Find information on our products including resources for patients.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard .
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.
Amoxil, Nucala and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies.